Hygieia Closes $17M Series B Funding Round
- Hygieia, a Livonia, MI-based digital health company, raised $17M in Series B funding
- The round was led by Firstime Ventures with participation from existing investors
- The company intends to use the funds to expand partnerships with endocrinology practices and access to its d-Nav® insulin dose automation technology for people with type 2 diabetes
- The company provides an insulin therapy and maker of the d-Nav® Insulin Management Program
- The d-Nav program includes an AI-powered application that helps people with type 2 diabetes use insulin in a safe and effective way to control their blood sugar levels
